Psych Congress 2017

View analytic

7:00am

Registration TBA

7:15am

Kick-off Presentation TBA

7:30am

Innovation Theater (Non-CME): A Long-Acting Injectable (LAI) Treatment for Schizophrenia with a New Dosing Interval Option La Nouvelle Orleans C

8:50am

Advanced Psychopharmacology Preconference: Real Patients. Real Problems. Real Solutions. La Nouvelle Orleans AB

12:10pm

Innovation Theater (Non-CME): A Discussion of the Science and Clinical Decision-Making Behind Bipolar Depression Diagnosis La Nouvelle Orleans C

4:30pm

Kickoff Keynote Address — Neurocognition of Food: Culinary Medicine and the Role of Food in Psychiatry La Nouvelle Orleans C

6:15pm

Disrupting Mental Illness: Advancing Technologies, Improving Lives (Non-CME) Hall E-2

7:30am

Relishing the Past and Welcoming the Future: Examining Psychiatry's Recent and Future Breakthroughs La Nouvelle Orleans A - C

9:00am

New Developments in the Treatment of Social Anxiety Disorder Hall E-3 New Developments in Our Thinking about Personality Disorders Hall E-2 Solving Clinical Challenges in Major Depression Hall E-1 The Truth About Shared Decision Making Room 245

10:30am

ADHD and Substance Use Disorders: An Intoxicating Combination Hall E-2 Navigating the Nuances of Mood Disorders Diagnosis Hall E-3 Suicide Risk Assessment and Malpractice Prevention Hall E-1 Has Asperger's Disorder Died? Room 245

12:00pm

Innovation Theater (Non-CME): A Development in ADHD: Presenting a Treatment Option for Adults La Nouvelle Orleans A - C

1:45pm

Advancing the Long-Term Management of Substance Use Disorders Through Medication-Assisted Treatment Strategies Hall E-2 A Review of the Science and Practical Applications of TMS Hall E-3 Obsessive-Compulsive Disorder: Treatment with Psychotherapy and Pharmacotherapy Hall E-1

3:15pm

Aging, Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer’s Disease Hall E-3 Examining the Limitations of Monoamine-Directed Therapy in Major Depressive Disorder: Novel Mechanisms and Treatment Targets Hall E-2 How Changing Cannabis Policies Will Affect Your Practice Hall E-1

4:45pm

Connecting Music to Mental Health La Nouvelle Orleans A - C

6:00pm

Opening Night Reception in the Exhibit Hall New Orleans Ernest N. Morial Convention Center

7:45pm

Psych Congress 30th Anniversary Celebration Mardi Gras World: The New Orleans Mardi Gras Museum

7:00am

Industry-Supported Symposia: Advances in the Management of Tardive Dyskinesia La Nouvelle Orleans AB Industry-Supported Symposia: Tackling the Spectrum of Symptom Domains in Schizophrenia: Tailoring Treatment to Address Patient Needs La Nouvelle Orleans C

9:15am

Preparing for Unplanned Pregnancies in Your Practice: What you Need to know Room 245 Solving Clinical Challenges in Bipolar Disorder Hall E-3 Advances in Understanding and Treating Autism Spectrum Disorders Hall E-1 Overcoming the 7 Common Perils of Telepsychiatry Hall E-2

10:45am

Postpartum Mood Disorders Hall E-3 Opioid Dependence: The Crossroads Between Pain and Addiction Hall E-2 Love is a Drug: Clinical Relevance of Early Life Adversity and Relationship Disturbances Hall E-1 Connected Health Technologies and Mobile Apps for Mental Health Room 245

12:15pm

Innovation Theater (Non-CME): Beyond Childhood: Recognizing ADHD in Adults Room 255 Innovation Theater (Non-CME): IN PLAIN VIEW: Exploring a Once-Monthly LAI Treatment Option Room 252 Innovation Theater (Non-CME): New Treatment for Tardive Dyskinesia: A Case-Based Approach Room 356 Innovation Theater (Non-CME): Recognizing and Treating Major Depressive Disorder Room 353 Exhibit Hall and Poster Pavilion New Orleans Ernest N. Morial Convention Center

12:30pm

Product Showcase: Genomind: Your Mental Health Partner in the Era of Personalized Medicine Theater #1 in Exhibit Hall D

1:30pm

Psych Congress Network Live! New Orleans Ernest N. Morial Convention Center Poster Presentations New Orleans Ernest N. Morial Convention Center

2:45pm

The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients Hall E-3 Is Psychiatry Safe? De-escalating Agitated and Violent Patients Hall E-1 Optimizing Treatment in Schizophrenia: An Update Hall E-2

4:15pm

My Path Through Life with Autism La Nouvelle Orleans A - C

5:30pm

Exhibit Hall Reception and Poster Gala New Orleans Ernest N. Morial Convention Center

5:45pm

Psych Congress Network Live! New Orleans Ernest N. Morial Convention Center

7:00am

Industry-Supported Symposia: New Advances in the Management of Tardive Dyskinesia La Nouvelle Orleans AB Industry-Supported Symposia: New Developments in Bipolar Spectrum Disorders in Children and Adolescents La Nouvelle Orleans C

9:15am

Solving Clinical Challenges in Substance Use Disorders Room 245 Update on Treatment-Resistant Major Depressive Disorder Hall E-3 Pharmacological Augmentation of Evidence-Based Treatment for PTSD: Emerging Methods Toward the Individualization of Treatment Protocols Hall E-2 Addressing Pharmacologic Issues in Insomnia Hall E-1

10:45am

More Attention. Less Stimulants. Hall E-2 Summary of the ABPN MOC Program: Life-Long Learning for Psychiatrists and Neurologists Room 245 Examining the Risks and Benefits from Benzodiazepines Hall E-3 Biological Rhythms and Wellness: The Roles of Sleeping and Eating Hall E-1

12:15pm

Innovation Theaters (Non-CME): A Long-Term Treatment Plan for Patients with Schizophrenia Room 353 Innovation Theaters (Non-CME): Learn More About an Adjunctive Treatment for Adults with Major Depressive Disorder Room 252 Innovation Theaters (Non-CME): Treatment Advances in Parkinson’s Disease Psychosis: Transforming the Standard of Care for Hallucinations and Delusions Room 356 Innovation Theaters (Non-CME): Update in the Management of Tardive Dyskinesia Room 255 Exhibit Hall and Poster Pavilion New Orleans Ernest N. Morial Convention Center

12:30pm

Product Showcases in the Exhibit Hall New Orleans Ernest N. Morial Convention Center

1:30pm

Psych Congress Network Live! New Orleans Ernest N. Morial Convention Center Poster Presentations New Orleans Ernest N. Morial Convention Center

2:45pm

Treating Children and Adolescents with Mood Disorders Hall E-1 The NYU Psilocybin Cancer Project Hall E-2 Weight Gain and Metabolic Abnormalities in Patients with Schizophrenia Hall E-3

4:15pm

DSM-5 Schizophrenia Spectrum and Other Psychotic Disorders: Knowing It Better and Improving Clinical Practice Hall E-3 Psychiatry Meets the Microbial World Hall E-2 Boundary Issues in Clinical Practice Hall E-1

5:45pm

Reexamining “Depression” and Antidepressants: A New Approach La Nouvelle Orleans A - C

7:00pm

Innovation Theater (Non-CME): A Novel Delivery System for Stimulant Medications for the Treatment of ADHD Room 252

7:00am

Industry-Supported Symposia: Nonadherence in Schizophrenia: Investigating the Clinical Utility of Long-Acting Injectable Antipsychotics on Treatment Adherence La Nouvelle Orleans AB

9:15am

Delivering and Measuring the Outcomes of Cognitive Remediation Across Clinical Settings Hall E-3 The Promise and Perils of Ketamine in Psychiatric Practice Hall E-2 Creating a Mental Wellness Practice Incorporating HERO Principles (Happiness, Enthusiasm, Resilience and Optimism) Hall E-1

10:45am

Successful Aging in Dementia: Pitfalls and Promises Hall E-1 Dopamine Receptor Pharmacology: What We Clinicians Need to Know Hall E-2

12:15pm

Innovation Theater (Non-CME): MDD: Looking Beyond Monoaminergic Pathways La Nouvelle Orleans AB

1:45pm

Out with the Old — In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Hall E-2

3:00pm

Walk on the Wild Side or Walk on the Right Side? The Role of Psychedelics, Cannabinoids, and Opioids in Psychiatric Treatment Hall E-2

4:15pm

Psych Congress 2017: Final Thoughts and Panel Discussion Hall E-2